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M O L E C U L A R  B I O L O G Y
TbRAP1 has an unusual duplex DNA binding activity 
required for its telomere localization and VSG silencing
Marjia Afrin1*, Amit Kumar Gaurav1*, Xian Yang2, Xuehua Pan2, Yanxiang Zhao2†, Bibo Li1,3,4†
Localization of Repressor Activator Protein 1 (RAP1) to the telomere is essential for its telomeric functions. 
RAP1 homologs either directly bind the duplex telomere DNA or interact with telomere-binding proteins. We 
find that Trypanosoma brucei RAP1 relies on a unique double-stranded DNA (dsDNA) binding activity to achieve 
this goal. T. brucei causes human sleeping sickness and regularly switches its major surface antigen, variant 
surface glycoprotein (VSG), to evade the host immune response. VSGs are monoallelically expressed from 
subtelomeres, and TbRAP1 is essential for VSG regulation. We identify dsDNA and single- stranded DNA binding 
activities in TbRAP1, which require positively charged 737RKRRR741 residues that overlap with TbRAP1’s nuclear 
localization signal in the MybLike domain. Both DNA binding activities are electrostatics- based and sequence 
nonspecific. The dsDNA binding activity can be substantially diminished by phosphorylation of two 737RKRRR741- 
adjacent S residues and is essential for TbRAP1’s telomere localization, VSG silencing, telomere integrity, and cell 
proliferation.
INTRODUCTION
Telomeres, the nucleoprotein complex at chromosome ends, can 
form a specialized heterochromatic structure that suppresses ex-
pression of genes located at the subtelomere, which is known as 
telomere position effect or telomeric silencing (1). Among known 
telomere core components, Repressor Activator Protein 1 (RAP1) is 
one of the most conserved, with homologs identified from protozoa 
to mammals (2–6). Although RAP1 homologs do not all have the 
same functions, most have been shown to play key roles to protect 
the chromosome end, maintain stable telomere length, and establish/
maintain the telomeric silencing (7).
The telomere function of RAP1 homologs depends on their localiza-
tion at the telomere. Most RAP1 homologs do not have any direct DNA 
binding activity, despite the presence of a Myb domain that typically 
has DNA binding activities (8). Instead, these RAP1s are tethered to 
the telomere through interaction with other telomere- binding proteins, 
such as TTAGGG repeat-binding factor 2 (TRF2) in humans (2) and 
Taz1 in Schizosaccharomyces pombe (4). So far, budding yeast RAP1s, 
including Saccharomyces cerevisiae RAP1, are the only ones that 
bind the duplex telomere DNA, recognizing a consensus sequence 
5′ ACACCCAYACAYY 3′ (where Y represents a pyrimidine) (9) 
using both its Myb and MybLike domains (10). The DNA binding 
domain of ScRAP1 is the only region essential for cell viability (11).
We have identified a RAP1 homolog in Trypanosoma brucei, a 
protozoan parasite that causes human African trypanosomiasis. 
The bloodstream form (BF) T. brucei proliferates in the extracellu-
lar space of the mammalian host and regularly switches its major 
surface antigen, variant surface glycoprotein (VSG), to evade the host 
immune response (12). There are ~2500 VSG genes and pseudogenes 
in the T. brucei genome (13). However, VSG is expressed exclusively 
from subtelomeric VSG expression sites (ESs), in which VSG is lo-
cated within 2 kb from the telomere repeats (14). T. brucei has 
multiple BF ESs (14), but only one is fully transcribed at any time, 
presenting a single type of VSG on the cell surface (15). Monoallelic 
VSG expression is regulated by multiple factors, such as chromatin 
structure, subnuclear localization of the VSG transcription site, ino-
sitol phosphate pathway, a subtelomere and VSG-associated VSG- 
exclusion (VEX) complex, and telomeric silencing (6, 16–19). VSG 
switching has two major pathways (20). A coupled silencing of the 
active ES and de repression of a silent ES leads to an in situ switch, 
and a silent VSG gene can be recombined into the active ES to 
replace the originally active VSG. Telomere proteins (21–23) and 
many factors important for homologous recombination, DNA 
damage repair, and DNA replication have been shown to influence 
VSG switching frequencies (24).
We identified TbRAP1 as a TbTRF-interaction factor (6), while 
TbTRF binds the duplex TTAGGG repeats of T. brucei telomere (25). 
TbRAP1 associates with the telomere chromatin and is partially co-
localized with TbTRF (6). We previously showed that depletion of 
TbRAP1 leads to a marked derepression of all ES-linked VSGs (6, 19). 
The TbRAP1-mediated silencing has a stronger effect on telomere 
proximal genes than those located further away, suggesting that lo-
calization of TbRAP1 at the telomere is essential for this silencing 
(6). Our previous study showed that association of TbRAP1 with 
the telomere chromatin helps suppress the expression of telomeric 
transcript [telomeric repeat-containing RNA (TERRA)], while an in-
creased amount of TERRA and telomeric R-loops in TbRAP1-depleted 
cells leads to more telomeric/subtelomeric DNA damage (23). These 
findings suggest that the telomere localization of TbRAP1 is also a 
prerequisite for telomere integrity. However, the mechanism of re-
cruiting TbRAP1 to the telomere was unknown.
TbRAP1 has both a Myb and a MybLike domain (6), but their 
roles in targeting TbRAP1 to the telomere have not been investigated, 
even though the Myb domain is a common structural motif for 
DNA binding activities (8). In this study, we find that the telomere 
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localization of TbRAP1 is independent of its Myb domain and 
TbTRF. Unexpectedly, within the TbRAP1 MybLike domain and over-
lapping with nuclear localization signal (NLS), we identify 737RKRRR741, 
a group of positively charged residues, to have both double-stranded 
DNA (dsDNA) and single-stranded DNA (ssDNA) binding activi-
ties. We show that 737RKRRR741 is required for the association of 
TbRAP1 with the telomere chromatin, VSG silencing, telomere in-
tegrity, and normal cell growth. Phosphorylation of the R/K patch–
adjacent S742 and S744 was detected in T. brucei cells (26, 27). We 
further demonstrate that the phospho-mimicking mutation of these 
S residues substantially diminishes TbRAP1’s dsDNA binding activity 
in vitro and abolishes TbRAP1’s telomere localization, causes VSG 
derepression, accumulates telomere/subtelomere DNA damage, and 
leads to cell growth arrest. Our results indicate that the dsDNA 
binding activity of TbRAP1 is essential and can be regulated by 
posttranslational modification of TbRAP1.
RESULTS
Localization of TbRAP1 to the telomere is independent 
of TbTRF and the Myb domain
TbRAP1 is an intrinsic component of the T. brucei telomere com-
plex (6), but how TbRAP1 is located to the telomere was unknown. 
Because TbTRF binds the duplex telomere DNA and interacts with 
TbRAP1 (6, 25), we tested whether TbRAP1 is recruited to the telo-
mere by TbTRF. A hemagglutinin (HA) monoclonal antibody 12CA5 
was used to chromatin immunoprecipitate (ChIP) the FLAG-HA-HA 
(F2H)–tagged TbRAP1 in TbRAP1F2H+/− TbTRF RNA interference 
(RNAi) cells (table S1 lists all strains used in this study). Before and 
after the depletion of TbTRF (Fig. 1A), TbRAP1 associated with the 
telomere chromatin at nearly the same level (Fig. 1B). As a control, 
TbTRF was no longer at the telomere after the RNAi induction 
(Fig. 1B). Therefore, the localization of TbRAP1 at the telomere is 
TbTRF independent.
TbRAP1 has a putative Myb domain (Fig. 1C) (6). While Myb 
motifs frequently bind DNA, the role of TbRAP1’s Myb domain 
in localizing TbRAP1 to the telomere was unknown. We have estab-
lished the TbRAP1F/∆M strain, in which one TbRAP1 allele was re-
placed with the ∆Myb (∆M) mutant, and the other (F allele) was 
flanked by loxP repeats so that it can be deleted when Cre is ex-
pressed (28). F2H-TbRAP1∆M expressed at the same level as F2H-
TbRAP1, and Cre induction depleted the wild-type (WT) TbRAP1 
protein within 30 hours (28). In TbRAP1F2H+/− and Cre-expressing 
TbRAP1F/∆M cells, ChIP using the HA antibody 12CA5 and a rabbit 
TbTRF antibody (25) showed that F2H-TbRAP1∆M was located at 
the telomere the same as F2H-TbRAP1, and TbTRF associated with 
the telomere chromatin in both cells (Fig. 1D). Therefore, the Myb 
domain is not necessary for localizing TbRAP1 to the telomere.
TbRAP1 has electrostatics-based DNA binding activities that 
rely on 737RKRRR741
TbRAP1 also has a MybLike domain [amino acids (aa) 639 to 761] 
(Fig. 1C) (6), which contains a positively charged 737RKRRR741 
patch. To test whether this domain has any DNA binding activity, we 
partially purified the recombinant TrxA-His6–tagged TbRAP1639–761, 
TbRAP1639–733, and TbRAP1734–761 from Escherichia coli (fig. S1A; 
table S2 lists all recombinant proteins used in this study) and per-
formed electrophoretic mobility shift assay (EMSA). TbRAP1639–761 
and TbRAP1734–761 bound a dsDNA containing (TTAGGG)12, a 100–
base pair (bp) dsDNA and a 100-nucleotide (nt) ssDNA containing 
a random sequence (Fig. 2, A to C), while TbRAP1639–733 or TrxA-
His6 did not bind these DNA substrates (Fig. 3E and fig. S1, B to E) 
(table S3 lists the sequences of all EMSA substrates used in this 
study). In addition, dsDNA with either (TTAGGG)12 or a random se-
quence competed for TbRAP1639–761’s binding when a (TTAGGG)12- 
containing dsDNA was used as the probe (fig. S1M), indicating that 
the DNA binding activity is sequence nonspecific. We also tested 
the DNA binding activity of glutathione S-transferase (GST)–tagged 
TbRAP1414–855 (fig. S1A) and got the same results (fig. S1, F to H). 
Therefore, TbRAP1 has sequence-nonspecific dsDNA and ssDNA 
binding activities in the aa 734 to 761 region, which we named DNA 
binding (DB; Fig. 1C).
To pinpoint which residues are critical for TbRAP1’s DNA bind-
ing activities, we used nuclear magnetic resonance (NMR) to ana-
lyze the heteronuclear single-quantum correlation (HSQC) spectrum 
of 15N-labeled TbRAP1639–761 in the presence and the absence of 
DNA substrates (Fig. 2D and fig. S1I). The HSQC spectra showed that 
positively charged residues K738 and R741 within the 737RKRRR741 
patch (the R/K patch) underwent notable chemical shifts when a 
dsDNA with a random sequence was added (Fig. 2D). Similar pat-
terns of chemical shifts were obtained when ds(TTAGGG)3 was 
added (fig. S1I). These data suggest that the R/K patch is directly 
responsible for the TbRAP1’s dsDNA binding. Notably, the HSQC 
signal for many residues in the MybLike domain preceding the R/K 
patch disappeared after the addition of DNA substrates (Fig. 2D 
and fig. S1I). This is likely due to the broadening of the HSQC signal 
for these residues after the formation of a larger-sized TbRAP1-DNA 
complex rather than direct interaction between these residues and 
the DNA substrate.
To confirm the importance of the R/K patch in DNA binding, 
we generated a TbRAP1639–7615A mutant with all five R and K resi-
dues replaced by A (fig. S1A). No chemical shifts were observed when 
dsDNA of either random or telomeric sequence was added to the 
15N-labeled 5A mutant (Fig. 2E and fig. S1J). Therefore, 737RKRRR741 is 
directly responsible for TbRAP1’s DNA binding activities. This find-
ing is further corroborated by EMSA results, where TbRAP1639–7615A 
did not bind dsDNA or ssDNA (Fig. 2, A to C), indicating that 
these DNA binding activities are based on electrostatic attraction be-
tween positively charged 737RKRRR741 and the DNA substrates. We 
further determined Kd (equilibrium dissociation constant) values 
of TbRAP1639–761 binding to a 100-bp dsDNA and a 100-nt ssDNA 
with a random sequence to be 21.5 M and 310 nM, respectively 
(fig. S1, K and L).
TbRAP1639–761 bound dsDNA substrates with an apparent in-
creasing affinity when the substrate length increased from 60 to 
150 bp (Fig. 3A). In addition, using an 80-bp random-sequence 
dsDNA as the substrate, longer dsDNAs competed better than 
shorter ones (500 > 200 > 100 > 60 bp) (Fig. 3B). We observed the 
same preference of TbRAP1’s ssDNA binding activity. TbRAP1639–761 
bound shorter DNA oligos with weaker affinity (40 < 60 < 80 < 100 nt) 
(Fig. 3C). Therefore, TbRAP1 is different from its vertebrate and 
fission yeast homologs in that it has DNA binding activities. TbRAP1 
is also different from its budding yeast homologs in that its DNA 
binding activities are electrostatics based, sequence nonspecific, 
and substrate size dependent. Furthermore, the R/K patch is within 
TbRAP1’s NLS (aa 727 to 741; Fig. 1C) (28). Hence, TbRAP1 is 
unique among its homologs in that its NLS has dual roles in nuclear 
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Phospho-mimicking mutations of the R/K patch–adjacent  
S residues significantly affect TbRAP1’s dsDNA  
binding activity
TbRAP1’s DNA binding activities rely on the R/K patch and are 
apparently electrostatics based. Phosphoproteomic analyses showed 
that S742 and S744 of TbRAP1 are phosphorylated in T. brucei 
cells (26, 27). Because phosphorylation adds negative charges to the 
local environment, we speculate that phosphorylation of S742 and 
S744 may interfere with DNA binding. To test this, we expressed 
S742AS744A (2SA) and S742DS744D (2SD) mutants (fig. S1A) of 
TbRAP1639–761 to mimic nonphosphorylated and phosphorylated 
states, respectively. EMSA showed that TbRAP1639–7612SD lost nearly 
all the dsDNA binding activity, while TbRAP1639–7612SA still re-
tained most of it (Fig. 3D). Therefore, TbRAP1’s dsDNA binding 
activity is likely sensitive to phosphorylation of both S residues. Both 
2SA and 2SD mutants still bound the ssDNA, although 2SD has a 
slightly weaker activity than WT TbRAP1639–761 (Fig. 3E). With spe-
cific and substantial reduction in the dsDNA binding yet minimal 
impact on the ssDNA binding, the 2SD mutant allows us to differ-
entiate the functional significance of these two DNA binding activ-
ities in vivo. In addition, single mutants TbRAP1639–761S742D and 
TbRAP1639–761S744D (fig. S1N) bound both dsDNA and ssDNA the 
same as WT TbRAP1 (fig. S1O), suggesting that phosphorylation of 
both S residues is necessary to exert a detectable effect on dsDNA 
binding.
In vivo telomere localization of TbRAP1 requires the R/K 
patch and is disrupted by phospho-mimicking mutation 
of adjacent S residues
We have established a Cre-loxP–mediated conditional deletion sys-
tem for TbRAP1 (28). In TbRAP1F/+, we replaced the WT TbRAP1 
allele with F2H-tagged DB domain mutants to generate TbRAP1F/mut 
strains (fig. S2A). For mutants missing the functional TbRAP1 NLS 
(aa 727 to 741), we added an N-terminal SV40 NLS, which is suffi-
cient for nuclear import of TbRAP1 (28). Genotypes of TbRAP1F/mut 
strains were confirmed by Southern (fig. S2B) and sequencing analyses.
To examine whether F2H-tagged TbRAP1 mutants are associated 
with the telomere chromatin, we performed ChIP using the HA anti-
body 12CA5 in TbRAP1F/mut cells. TbRAP1 self-interacts through 
its BRCA1 C-terminus (BRCT) domain (Fig. 1C) (28). Hence, we 
removed the WT TbRAP1 allele by Cre [confirmed by polymerase 
chain reaction (PCR); fig. S2C] to specifically examine TbRAP1 mu-
tants’ behavior without the influence from the WT protein. As a 
control, ChIP was done in TbRAP1F2H+/− using the 12CA5 anti-
body. All TbRAP1 mutants were expressed at the same level as 
F2H-TbRAP1, except ∆MybLike (∆ML) at a subtly lower level (Fig. 4A). 
Only a residual amount of TbRAP1∆ML (Fig. 4B), ∆DB (Fig. 4C), 
and 5A (Fig. 4D) mutants associated with the telomere chromatin, 
which was much lower than F2H-TbRAP1. TbTRF was still at the 
telomere in these mutants (Fig.  4,  B  to  D). Immunofluorescence 
(IF) analyses were done to examine the subnuclear localization of 
TbRAP1 point mutants. In TbRAP1F2H+/− cells, F2H-TbRAP1 par-
tially colocalized with TbTRF (Fig. 4E, top), the same as we report-
ed previously (6). However, TbRAP1-5A was no longer colocalized 
with TbTRF, even though it was imported into the nucleus via the 
SV40 NLS (Fig. 4E, bottom). Therefore, the R/K patch is required 
for the telomere localization of TbRAP1.
In addition, significantly less TbRAP1-2SD was associated with 
the telomere chromatin than F2H-TbRAP1 (Fig. 4F). IF also showed 
that TbRAP1-2SD did not colocalize with TbTRF (Fig. 4G), indicat-
ing that the TbRAP1’s dsDNA binding activity is critical for its 
localization at the telomere. In contrast, mutation of TbRAP1’s phos-
phorylation sites to A did not affect its telomere localization. Five 
TbRAP1 residues were found to be phosphorylated in T. brucei cells 
(26, 27), and the TbRAP1F/5SA strain was established previously with all 
five phosphorylation sites mutated to A (S265AS586AS742AS744A-
T752A). To specifically investigate the function of S742 and S744, 






































































Fig. 1. Telomere localization of TbRAP1 is independent of TbTRF and the Myb domain. (A) Protein lysates from TbRAP1F2H+/− TbTRF RNAi cells before and after adding 
doxycycline (Dox) were analyzed by Western blotting. A rabbit anti-TbTRF antibody (25) and the tubulin antibody TAT-1 (42) were used. In this and many other strains, 
TbRAP1 has an N-terminal FLAG-HA-HA (F2H) tag. (B) ChIP analysis using an HA monoclonal antibody (AB) 12CA5 (Memorial Sloan Kettering Cancer Center monoclonal 
AB Core) and a rabbit TbTRF antibody in TbRAP1F2H+/− TbTRF RNAi before and after depletion of TbTRF. DNA isolated from the ChIP products were hybridized with a telo-
mere probe and a 50-bp repeat probe in Southern blotting. Blots were exposed to a phosphorimager, and results were quantified by ImageQuant (GE Healthcare). Aver-
ages from three independent experiments were calculated. In this and other figures, error bars represent SD. (C) Domain structure of TbRAP1. The BRCT, Myb, MybLike, 
and RCT domains and the NLS (aa 727 to 741) were identified previously (6, 28). (D) ChIP analysis using the HA antibody 12CA5 and a rabbit TbTRF antibody in TbRAP1F2H+/− 
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Both TbRAP1-5SA and 2SA mutants associated with the telomere 
chromatin (Fig. 4H and fig. S2D). IF showed that 5SA and 2SA both 
partially colocalized with TbTRF (Fig. 4I and fig. S2E). Therefore, 
TbRAP1 with unphosphorylated S742 and S744 is localized at the 
telomere, while phosphorylation of both S742 and S744 can remove 
TbRAP1 from the telomere.
The telomere localization of TbRAP1 is essential for normal 
cell growth
We recently showed that the MybLike domain is essential for nor-
mal cell proliferation (28). To determine the functions of TbRAP1’s 
DNA binding activities specifically, we first examined cell growth in 
TbRAP1F/mut cells carrying DB mutations after induction of Cre. 
F2H-tagged TbRAP1 mutants were detected by the HA Probe anti-
body. The expression of total TbRAP1 was also examined by a rabbit 
antibody (6) that recognizes the MybLike domain (28) and, specifi-
cally, TbRAP1639–733 but not TbRAP1734–761 (fig. S2F).
Western analysis showed the deletion of WT TbRAP1 and a per-
sistent expression of F2H-NLS–tagged TbRAP1-∆DB (fig. S2G), 5A 
(Fig. 5A), and 2SD (Fig. 5C) mutants and F2H-tagged 5SA (fig. S2I) 
and 2SA (Fig. 5E) mutants in various TbRAP1F/mut cells upon Cre 
induction. TbRAP1F/∆DB (fig. S2H) and TbRAP1F/5A (Fig. 5B) cells 
exhibited a growth arrest after inducing Cre for 24 to 30 hours, in-
dicating that TbRAP1’s DNA binding activities are essential for 
normal cell growth. TbRAP1F/2SD cells showed a growth arrest upon 



































































































































Fig. 2. TbRAP1 has dsDNA and ssDNA binding activities that depend on 737RKRRR741 (the R/K patch). (A to C) TbRAP1734–761 has DNA binding activities (numbers 
indicate amino acid positions). EMSA experiments were done using TrxA-His6–tagged TbRAP1639–761, TbRAP1734–761, and TbRAP1639–7615A (737RKRRR741 mutated to 
737AAAAA741) and a radiolabeled dsDNA containing (TTAGGG)12 (A), a dsDNA with a random sequence (B), or a DNA oligo with a random sequence (C) as the probe. The 
amount (nanogram) of protein used is indicated on top of each lane. (D) Four overlapped HSQC NMR spectra of 15N-labeled TbRAP1639–761 in the absence (black) and 
presence of random dsDNA in 1× (green), 2× (blue), and 3× (red) molar excess. Labeled residues are within the R/K patch. Arrows indicate substantial chemical shifts after 
adding the DNA substrate. (E) Two overlapped HSQC NMR spectra of 15N-labeled TbRAP1639–7615A in the absence (black) and presence of random dsDNA in 3× (red) 
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the dsDNA binding without affecting ssDNA binding significantly 
(Fig. 3, D and E), this observation indicates that TbRAP1’s dsDNA bind-
ing is essential for normal cell proliferation. In contrast, TbRAP1F/5SA 
(fig. S2J) and TbRAP1F/2SA (Fig. 5F) cells only grew mildly slower 
after the WT TbRAP1 allele was deleted. Therefore, all TbRAP1 mu-
tants that were not localized at the telomere also experienced cell 
growth arrest, while those that were still at the telomere kept pro-
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Fig. 3. TbRAP1 has higher affinity for longer DNA substrates. (A) EMSA using TrxA-His6-TbRAP1639–761 and radiolabeled dsDNAs (of 60, 80, or 150 bp) containing a 
random sequence as the substrate. (B) EMSA using 250 ng of TrxA-His6-TbRAP1639–761 and a radiolabeled 80-bp dsDNA with a random sequence as the substrate. Non-
radiolabeled dsDNAs with a random sequence of 60, 100, 200, or 500 bp were used as competitors. The amounts of competitors are indicated as molar folds of the probe. 
(C) EMSA experiments were done using TrxA-His6-TbRAP1639–761 and a radiolabeled 100-, 80-, 60-, or 40-nt DNA oligo containing a random sequence as the substrate. 
(D and E) TbRAP1 S742 and S744 residues are important for the dsDNA binding activity. EMSA using TrxA-His6–tagged TbRAP1639–761, TbRAP1639–7612SA (S742AS744A), 
and TbRAP1639–7612SD (S742DS744D) and a radiolabeled dsDNA containing (TTAGGG)12 (D) or a 100-nt ssDNA with a random sequence (E) as the substrate. TrxA-His6 was 
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of cell proliferation, providing useful genetic tools for further inves-
tigation of TbRAP1’s functions in the future.
The R/K patch–mediated dsDNA binding activity of TbRAP1 
is essential for VSG silencing
We previously hypothesized that the telomere localization of TbRAP1 
is a prerequisite of normal VSG silencing (6). To test this, we examined 
mRNA levels of several ES-linked VSGs in domain deletion mutants 
and transcriptomic profiles in point mutations that lost TbRAP1’s 
dsDNA binding activity. By quantitative reverse transcription PCR (qRT- 
PCR), we found that multiple ES-linked silent VSGs were derepressed 
several hundred-folds to thousand-folds in TbRAP1F/∆ML (fig. S3A) 
and TbRAP1F/∆DB (fig. S3B) cells after induction of Cre for 30 hours, 
indicating that the DB region is essential for VSG silencing.
RAP1 homologs are known to regulate expression of both sub-
telomeric and nontelomeric genes (3, 29, 30). We suspect that 
TbRAP1 may affect expression of genes other than VSGs. To exam-
ine TbRAP1’s function in global gene expression, we performed 
RNA sequencing (RNAseq) analysis in TbRAP1 point mutants that 
did not bind DNA. As a control, we first compared the gene expres-
sion profile in TbRAP1F/− and TbRAP1F/+ cells after both were 
induced for Cre expression for 30 hours. Compared to TbRAP1F/+ 
cells, >7200 genes were up-regulated in TbRAP1F/− cells (fig. S4A), 
among which >2500 were VSG genes and pseudogenes (fig. S4B). 
There are ~2500 VSG genes and pseudogenes in our T. brucei strain 
(13), suggesting that nearly all VSG genes were derepressed in 
TbRAP1F/− cells. All BF ES–linked VSGs were derepressed (fig. S5). 
Some ES-linked ESAGs were up-regulated, some were not affected 
significantly, and others were down-regulated (fig. S5), indicating 
that VSGs and ESAGs can be regulated differently by TbRAP1 even 
when they are located in the same ESs. In addition, >2500 genes 
were down-regulated upon TbRAP1 deletion, including a number 
of ribosomal protein genes (fig. S4, A and B). In consistence, Gene 
Ontology term analysis showed that genes involved in immune eva-
sion were up-regulated, and genes involved in protein synthesis 
were down-regulated (fig. S4E). However, much fewer genes were 
down-regulated than up-regulated, and the change in gene expres-
sion level is much stronger for up-regulated genes than that for 
down-regulated ones (fig. S4A), suggesting that TbRAP1 is mainly a 
repressor. Compared to TbRAP1F/+ cells, in Cre-induced TbRAP1F/5A 
cells, nearly 5300 genes were up-regulated (Fig. 5G), including 2119 VSG 
genes (fig. S4C), while >1400 genes were down-regulated (Fig. 5G), 
including 66 ribosomal protein genes (fig. S4C). All ES-linked VSGs 
were derepressed although at various levels (fig. S6). In addition, 
ES-linked ESAGs were up-regulated, unaffected, or down- regulated 
by the 5A mutation (fig. S6). Therefore, TbRAP1F/5A has a similar 
transcriptome profile as TbRAP1F/−, indicating that the R/K patch is 
essential for TbRAP1’s role in gene expression regulation. We 
observed a similar phenotype in TbRAP1F/2SD cells. Upon Cre in-
duction, nearly 7000 genes were up-regulated (Fig. 5H), including 
2574 VSG genes (fig. S4D), and >2100 genes were down-regulated 
(Fig. 5H), including 59 ribosomal protein genes (fig. S4D). All BF 
ES–linked VSGs were up-regulated although at various levels (fig. S7), 
and ESAGs were similarly affected as in TbRAP1F/− and TbRAP1F/5A 
cells (fig. S7). Therefore, TbRAP1’s dsDNA binding activity is required 
for its role in gene expression regulation.
In contrast, 5SA and 2SA mutants exhibited only mild VSG dere-
pression. In TbRAP1F/5SA and TbRAP1F/2SA cells, a number of silent 
VSGs were derepressed up to several 10-fold when analyzed by 
qRT-PCR after Cre induction for 30 hours (Fig. 5I and fig. S3C). 
Furthermore, IF analysis using a VSG3 mouse antibody and a VSG6 
rabbit antibody showed that these initially silent VSGs were both 
expressed in the same individual cells upon Cre induction, although 
a large fraction of the proteins was not deposited on the cell surface 
(Fig. 5K and fig. S3E), indicating that 5SA and 2SA caused VSG de-
repression. Since these mutants continued to proliferate, TbRAP1−/
5SA and TbRAP1−/2SA cells (after deleting the WT TbRAP1 allele by 
Cre) were cultured continuously. qRT-PCR showed that silent VSGs 
were expressed at a higher level in these cells than in TbRAP1−/+ 
cells (Fig. 5J and fig. S3D), indicating that VSG derepression is not 
just a transient phenotype in these mutants. Although 5SA and 2SA 
mutants are located at the telomere (Fig. 4, H and I, and fig. S2, D 






















































































































































































































































































DAPI TbRAP1-5A TbTRF Merge
5 µm
Fig. 4. The R/K patch is important for the telomere localization of TbRAP1. 
(A) Western analyses to compare expression of F2H-tagged TbRAP1 proteins. 
Whole-cell lysates were prepared from the indicated strains. The HA antibody 
12CA5 and tubulin antibody TAT-1 were used. ChIP experiments using the HA anti-
body 12CA5 and a TbTRF rabbit antibody were done in TbRAP1F2H+/− cells and Cre- 
induced (for 30 hours) TbRAP1F/∆ML (B), TbRAP1F/∆DB (C), TbRAP1F/5A (D), TbRAP1F/2SD 
(F), and TbRAP1F/2SA (H) cells. IF analyses were done in TbRAP1F2H+/− (E, top), TbRAP1F/5A 
(E, bottom), TbRAP1F/2SD (G), and TbRAP1F/2SA (I) cells. 12CA5 and a TbTRF chicken 
antibody (6) were used. DNA was stained by 4′,6-diamidino-2-phenylindole (DAPI). 
In this and other IF images, all images are of the same scale, and size bars are 
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Fig. 5. TbRAP1’s dsDNA binding activity is required for VSG silencing and normal cell growth. (A, C, and E) Western analysis of protein extracted from TbRAP1F/5A 
(A), TbRAP1F/2SD (C), and TbRAP1F/2SA (E) cells before and after induction of Cre for 30 hours using the HA monoclonal antibody HA Probe (Santa Cruz Biotechnologies), a 
TbRAP1 rabbit antibody (6), and the tubulin antibody TAT-1 (top three rows). To separate TbRAP1 mutants and the endogenous TbRAP1, proteins were run on a 7.5% tris 
polyacrylamide gel for 7 hours and detected by the TbRAP1 rabbit antibody (the fourth row). The associated loading control (tubulin blot) is shown at the bottom. (B, D, 
and F) Growth curves of TbRAP1F/5A (B), TbRAP1F/2SD (D), and TbRAP1F/2SA (F) cells with and without Cre. Average values from three independent experiments were calculated. 
(G and H) A volcano plot of genes up-regulated and down-regulated in TbRAP1F/5A (G) and TbRAP1F/2SD (H) cells compared to TbRAP1F/+ cells 30 hours after Cre induction. 
(I and J) qRT-PCR of mRNA levels of the active VSG2, several silent ES-linked VSGs, and chromosome internal TbTERT and ribosomal RNA (rRNA) in TbRAP1F/2SA cells after 
30 hours of Cre induction (I) and in TbRAP1−/2SA cells (J). The fold changes in mRNA level are shown. Average was calculated from three to six independent experiments. 
(K) VSG6 and VSG3 expression was examined in TbRAP1F/2SA cells before and after Cre induction (left) and in TbRAP1−/2SA cells (right) by IF analyses. A VSG6 rabbit antibody 
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WT protein (Fig. 3D). Therefore, these observations further indicate 
that the dsDNA binding activity is critical for VSG silencing.
The telomere localization of TbRAP1 is required 
for subtelomere/telomere integrity
We cannot estimate the VSG switching frequency in mutants that 
exhibited growth arrest, because recovering switchers relies on cell 
proliferation, and the Cre-loxP–mediated TbRAP1 deletion is not 
reversible. However, subtelomeric DNA damage, particularly that 
in the active ES, is a potent inducer of VSG switching (31, 32), and 
we previously showed that TbRAP1 suppresses VSG switching by 
maintaining telomere/subtelomere integrity (23). Therefore, we ex-
amined DNA damage in all TbRAP1 mutants, using H2A as an 
indicator (33). Western blotting showed that the H2A level increased 
upon Cre induction in TbRAP1F/∆ML (Fig. 6A), TbRAP1F/∆DB 
(Fig.  6B), TbRAP1F/5A (Fig.  6B), and TbRAP1F/2SD (Fig.  6C) cells. 
We also performed H2A IF in TbRAP1F/5A and TbRAP1F/2SD cells 
before and after Cre induction. There were only few H2A-positive 
nuclei (~7%) in both cells before adding Cre (Fig. 6D), and the H2A 
signal was faint. In contrast, after Cre induction, more than 90% of 
nuclei were H2A positive (Fig. 6D), and the H2A signal was very 
bright (Fig. 6E). However, H2A gave a punctate staining pattern in 
both induced TbRAP1 mutant cells, suggesting that the increase in 
DNA damage is not throughout the whole genome. In addition, we 
detected TbTRF in IF as a marker for the telomere and found that 
H2A is partially colocalized with TbTRF (Fig. 6E), suggesting 
that some of the DNA damage is at the telomere vicinity. We subse-
quently performed H2A ChIP in the 5A and 2SD mutants. South-
ern hybridization using telomere and tubulin probes following 
H2A ChIP showed that more H2A associated with the telomere 
chromatin but not with the tubulin chromatin in TbRAP1F/5A 
and TbRAP1F/2SD than in TbRAP1F/+ cells after Cre induction 
(Fig. 6F). H2A ChIP followed by qPCR in TbRAP1F/5A (Fig. 6G) 
and TbRAP1F/2SD (Fig. 6H) cells also showed significantly more 
H2A at the active ES, including VSG2 and 70-bp repeats loci upon 
Cre induction. Therefore, there is an increased amount of DNA damage 
at the telomere and in the active ES when TbRAP1 is no longer located 
at the telomere. In contrast, 5SA and 2SA did not increase the H2A 
level (Fig. 6I and fig. S3F) and were still localized at the telomere (Fig. 4, 
H and I, and fig. S2, D and E), further supporting this conclusion.
In IF analysis, few Cre-expressing TbRAP1F/5SA cells (fig. S3E) and 
TbRAP1−/2SA cells (Fig. 5K) expressed a relatively high level of VSG6 
on the cell surface, suggesting that these cells may have gone through 
a VSG switching and that 5SA and 2SA mutants may affect VSG 
switching frequency. We estimated the VSG switching rate in 
TbRAP1−/5SA, TbRAP1−/2SA, and TbRAP1−/+ cells—all of which initially 
expressed VSG2. VSG switchers were enriched by passing cells through 
a magnetic-activated cell sorting column coupled with a VSG2 mono-
clonal antibody and verified by Western slot blot using a VSG2 rabbit 
antibody (without the cross-reaction portion). Compared to TbRAP1−/+ 
cells, TbRAP1−/2SA and TbRAP1−/5SA cells had a twofold and four- to 
fivefold higher VSG switching rate, respectively (Fig. 6J). Therefore, 5SA 
and 2SA are also mildly defective in suppression of VSG switching.
DISCUSSION
In this study, we identified both dsDNA and ssDNA binding activ-
ities of TbRAP1 in a positively charged R/K patch that overlaps with 
TbRAP1’s NLS in the MybLike domain. We showed that the dsDNA 
binding activity is essential for TbRAP1’s association with the telomere 
chromatin, VSG silencing, suppressing VSG switching, telomere integrity, 
and normal cell proliferation. Our study revealed a key and previous 
unidentified mechanism underlying the essential functions of TbRAP1.
An unusual electrostatics-based DNA binding activity 
required for targeting TbRAP1 to the telomere
Targeting TbRAP1 to the telomere chromatin requires a unique 
mechanism among known RAP1s. First, although TbRAP1 inter-
acts with the duplex telomere DNA binding factor TbTRF (6), its 
localization at the telomere is TbTRF independent, which is different 
from the scenarios in vertebrates and fission yeast (10, 34). Second, 
TbRAP1’s DNA binding activities are unusual, because it binds to 
both dsDNA and ssDNA substrates, while RAP1s in budding yeasts 
bind dsDNA (5, 10). In addition, TbRAP1’s DNA binding activities 
are independent of its Myb domain, while most telomere DNA 
binding factors—including mammalian TRF1/2, fission yeast Taz1, 
budding yeast RAP1s, a number of plant telomere repeat–binding 
factors, and TbTRF—use a Myb-type helix-turn-helix motif to rec-
ognize the telomere DNA (25, 35, 36). Furthermore, the TbRAP1’s 
DNA binding activities are electrostatics based and sequence non-
specific. In contrast, ScRAP1 recognizes a substrate with the consensus 
sequence 5′ ACACCCAYACAYY 3′ (9).
Mutation of 737RKRRR741 to AAAAA disrupts the association of 
TbRAP1 and the telomere chromatin in vivo. However, because 
737RKRRR741 has both the dsDNA and ssDNA binding activities, it 
was unclear whether both activities are required for the telomere 
localization of TbRAP1. Fortunately, the S742DS744D mutation 
disrupts most dsDNA binding, retains nearly all ssDNA binding, 
and is not localized at the telomere, indicating that the dsDNA 
binding activity is the key for localization of TbRAP1 at the telo-
mere. It is interesting that the TbRAP1’s DNA binding activities are 
sequence nonspecific, yet ChIP and IF analyses indicate that TbRAP1 
is enriched at the telomere much more than at other chromosome 
loci such as 50-bp repeats upstream of BF ESs. Therefore, additional 
mechanism(s) is (are) necessary to help TbRAP1 to discriminate 
different loci. ScRAP1 is well known to bind the promoter of a num-
ber of genes and several silencers in addition to the telomere (3), 
and interaction with different protein partners apparently plays a 
key role in targeting ScRAP1 to different chromatin loci (7). A sim-
ilar scenario may apply to TbRAP1, although further investigation 
is necessary to illustrate the underlying mechanisms.
The dsDNA binding activity of TbRAP1 can be regulated by 
posttranslational modification
We showed that TbRAP1’s DNA binding activities are mediated by 
electrostatically favorable interaction between the positively charged 
737RKRRR741 patch and the negatively charged DNA substrate. In 
addition, the phospho-mimicking S742DS744D mutant substantially 
disrupts the dsDNA binding activity, presumably due to unfavorable 
electrostatic interaction between the D residues and the DNA sub-
strate. Phosphoproteomic studies detected phosphorylated TbRAP1 
at S742 and S744 residues in both the infectious and insect stages of 
T. brucei (26, 27). Therefore, phosphorylation of both S742 and 
S744 in vivo, hence decreasing the amount of positive charges adja-
cent the R/K patch, can serve as an important mechanism to regulate 
TbRAP1’s dsDNA binding activity and, subsequently, VSG silencing. 
This regulatory mechanism can be a key for achieving monoallelic 
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subtelomeric VSGs except the one in the active ES. With a means to 
regulate the dsDNA binding activity, it is possible that TbRAP1 may 
be prevented from interacting with the active ES DNA and estab-
lishing local silencing, thus leaving the active VSG fully transcribed. 
However, little is known how regulation of TbRAP1’s dsDNA bind-
ing activity is achieved in vivo. Quantitative proteomic analysis sug-
gested that phosphorylation of the S residues may be at a very subtly 
higher level (~1.4-fold) in BF cells than in cells at the insect stage (27). 
However, it is unknown whether these phosphorylations are cell cycle 
regulated. Our current study revealed potential physiological signif-
icance of these posttranslational modifications of TbRAP1. Further 
studies, such as identification of the kinase that phosphorylates S742 
and S744 and the signals that activate the phosphorylation of these 
S residues, are key to understand the mechanism of this regulation.
Possible cross-talk between telomere localization 
and nuclear import of TbRAP1
It is interesting that the R/K patch overlaps with the TbRAP1 NLS 
(28), indicating that this short peptide has at least two functions. 
Nuclear import per se mediated by SV40 NLS is not sufficient to 
ensure telomere localization of TbRAP1. Rather, the dsDNA bind-
ing activity is required. The fact that DNA binding activities of 
TbRAP1 rely on the same peptide that signals for nuclear import 







































































































































































































































































Fig. 6. Nontelomere-localized TbRAP1 mutants have an increased amount of DNA damage at the telomere/subtelomere. (A to C and I) Western analysis to exam-
ine the H2A protein level in WT cells before and after phleomycin treatment (as a positive control) and in TbRAP1F/∆ML (A), TbRAP1F/∆DB (B), TbRAP1F/5A (B), TbRAP1F/2SD 
(C), and TbRAP1F/2SA (I) cells before and after Cre induction and in TbRAP1−/2SA and uninduced TbRAP1F/2SA cells (I). A H2A rabbit antibody (23) and the tubulin antibody 
TAT-1 were used. (D) Percent of H2A-positive nuclei in TbRAP1F/5A and TbRAP1F/2SD cells before and after Cre induction. (E) IF analysis using a TbTRF rabbit antibody (25) 
and a H2A rabbit antibody (23) in TbRAP1F/5A and TbRAP1F/2SD cells before and after Cre induction. DNA was stained by DAPI. Merged images with signals from three 
channels are shown for −Cre cells (top). Images showing signals from individual and merged channels are shown in +Cre cells (bottom). (F) ChIP using the H2A rabbit 
antibody and immunoglobulin G (IgG) in TbRAP1F/5A, TbRAP1F/2SD, and TbRAP1F/+ cells after 30 hours of Cre induction followed by Southern blotting using a telomere and 
a tubulin probe. Blots were exposed to a phosphorimager. Images were quantified using ImageQuant, and average values were calculated from three independent ex-
periments. P values of unpaired t tests (mutant versus control cells) are shown. (G and H) ChIP using a H2A rabbit antibody and IgG in TbRAP1F/5A (G) and TbRAP1F/2SD 
(H) cells followed by qPCR using primers specific to the indicated active and silent ES loci. SNAP50 is a chromosome internal gene. Average enrichment (ChIP/input) was cal-
culated from three to six independent experiments. P values of unpaired t tests (H2A ChIP products, +Cre versus −Cre) are shown. (J) VSG switching rates in TbRAP1−/5SA, 
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be regulated. A recent structural study showed that importin-9 binds 
histone H2A-H2B and functions more like a storage chaperon (37). 
After H2A-H2B is transported into the nucleus, RanGTP does not 
directly dissociate the importin-9 and H2A-H2B interaction. Rather, 
the RanGTP•importin-9•H2A-H2B complex helps modulate the 
dissociation of importin-9 from H2A-H2B by DNA and assemble 
the histones into a nucleosome. It is possible that the interaction of 
importin  and TbRAP1 NLS may be disrupted only after TbRAP1 
binds DNA. However, more detailed structural and functional anal-
yses are necessary to test this hypothesis.
TbRAP1’s functions in VSG silencing and normal cell 
proliferation are independent
TbRAP1 is essential for VSG silencing and normal cell proliferation 
(6, 19). However, whether the two functions are linked or indepen-
dent was unknown. Most TbRAP1 mutants simultaneously show 
defects in both VSG silencing and cell growth, preventing us from 
independently dissecting the two functions. In addition, many other 
genes that are involved in VSG silencing are also essential, such as key 
factors in the inositol phosphate pathway, origin recognition complex 1 
(ORC1) and minichromosome maitenance protein complex-binding 
protein (MCM-BP), the VEX complex, etc. (38).
5SA and 2SA from this study are the only two TbRAP1 mutants 
capable of cell proliferation, even though they also caused VSG 
derepression, indicating that VSG silencing and cell growth are not 
tightly coupled. A recent study showed similar uncoupling between 
VSG silencing and cell proliferation, where overexpression of Try-
panosome DNA-binding Protein 1 (TDP1) leads to simultaneous 
multiple VSG expression without significantly affecting cell growth 
(39). Therefore, loss of VSG monoallelic expression per se is not 
lethal for T. brucei. Nevertheless, TbRAP1 mutants that have defec-
tive dsDNA binding are also defective in VSG silencing. For 5SA and 
2SA, mildly weaker dsDNA binding activity is most likely the rea-
son for the mild VSG derepression phenotype.
We found that all TbRAP1 mutants that lose the telomere asso-
ciation are defective in cell proliferation and have an increased 
amount of DNA damage at the telomere vicinity, suggesting that an 
increased amount of telomere damage contributes to the cell growth 
defects. ScRAP1’s DNA binding domain is also essential for cell vi-
ability (11). It is well known that ScRAP1 is required for transcrib-
ing a number of genes encoding ribosomal proteins, and the DNA 
binding domain is critical for ScRAP1’s transcription activation 
function (3). Therefore, defective ribosomal protein gene expres-
sion may be a major reason why the ScRAP1 null mutant is lethal. 
In TbRAP1 conditional knockout cells and mutants defective in 
telomere localization, 1400 to 2600 genes were down-regulated for 
their expression, although the change in their mRNA levels is mild. 
Among the affected are a number of ribosomal protein genes. The 
down-regulation of ribosomal protein genes would be deleterious 
to cell growth and likely another reason why TbRAP1 is essential for 
cell proliferation. However, further studies are necessary to verify 
the transcription activation function of TbRAP1.
In this study, we demonstrate that TbRAP1’s dsDNA binding 
activity is essential for localization of TbRAP1 to the telomere, cell 
proliferation, VSG silencing, and telomere/subtelomere integrity. 
This activity depends on a short stretch of positively charged resi-
dues that overlaps with TbRAP1’s NLS, which is unique among all 
known telomere binding factors. Our findings provide a molecular 
basis that the DNA binding domain of TbRAP1 may serve as a good 
target for antiparasite agents, as targeting this site can inactivate es-
sential TbRAP1 functions by blocking its nuclear import and dis-
rupting its DNA binding simultaneously.
MATERIALS AND METHODS
T. brucei strains and plasmids
All T. brucei strains used in this study (listed in table S1) are derived 
from BF Lister 427 cells that express VSG2 and express the T7 poly-
merase and the Tet repressor (also known as single marker or SM) 
(40). All BF T. brucei cells were cultured in HMI-9 medium supple-
mented with 10% fetal bovine serum and appropriate antibiotics.
TbRAP1F/+ was established previously and described in (28). 
All TbRAP1F/mut strains were established using the same strategy. 
N-terminal F2H-tagged and SV40 NLS-tagged TbRAP1∆ML (dele-
tion of the MybLike domain), TbRAP1∆DB, TbRAP1-5A, TbRAP1-
2SD, and F2H-tagged TbRAP1-5SA and TbRAP1-2SA mutants 
flanked by sequences upstream and downstream of the TbRAP1 
gene, together with a PUR marker, were cloned into pBlueScript SK 
to generate respective targeting constructs. All mutant-targeting plas-
mids were digested with Sac II before transfecting the TbRAP1F/+ 
cells to generate respective TbRAP1F/mut strains. All mutant strains 
were confirmed by Western and Southern analyses. Point mutations 
were also validated by sequencing PCR-amplified genomic DNA 
fragments (one PCR primer is specific to the F2H tag).
For examination of TbRAP1’s association with the telomere 
chromatin in the presence and absence of TbTRF, a TbTRF RNAi 
strain was first established by transfecting the Not I–digested pZ-
JM-TbTRF-Mid1 RNAi construct (25) into SM cells. Subsequent-
ly, one endogenous TbRAP1 allele was tagged with an N-terminal 
F2H tag by transfecting a Sac II–digested pSK-PUR-F2H-TbRAP1-
tar2 construct into the TbTRF RNAi cells. The other TbRAP1 allele 
was replaced by Hygromycin resistance (HYG) to establish the 
TbRAP1F2H+/− TbTRF RNAi strain. Bacterial expression plasmids used 
in this study are listed in table S2.
Quantitative reverse transcription polymerase  
chain reaction
qRT-PCR experiments were performed, as described in (22).
Chromatin immunoprecipitation
Two hundred million cells were cross-linked by 1% formaldehyde 
for 20  min at room temperature with constant mixing, and the 
cross-linking was stopped by 0.1 M glycine. Chromatin was sonicated 
by a Bioruptor for six cycles (each 30-s sonication and 30-s rest) at 
the high level to get DNA fragments of ~500 bp on average. After 
saving a small amount of sonicated sample as the input fraction, the 
sample was equally divided into three fractions, each incubating with 
12CA5, TbTRF antibody, or immunoglobulin G (IgG) conjugated 
with Dynabeads Protein G (Thermo Fisher Scientific) for 3 hours 
at 4°C. In H2A ChIP, the total lysate was equally divided into two 
fractions, each incubating with the H2A antibody or IgG conjugated 
with Dynabeads Protein G. After washing, immunoprecipitated prod-
ucts were eluted from the beads, and DNA was isolated from the prod-
ucts followed by Southern slot blot hybridization or qPCR analysis.
Recombinant protein expression and purification
Recombinant protein expression constructs were transformed into 
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samples used for EMSA studies were expressed in standard LB me-
dia. Proteins used for acquiring 15N HSQC NMR spectrum were 
expressed in M9 minimal media, with 15N-labeled ammonium chlo-
ride (15N, 98%+) (Cambridge Isotope Laboratories Inc.) as nitrogen 
source and d-glucose (Cambridge Isotope Laboratories Inc.) as 
carbon source. Protein expression was induced by isopropyl--d- 
thiogalactopyranoside. TrxA-His6–tagged proteins were purified 
with a His•bind resin (Millipore) according to the manufacturer’s 
protocol. GST-tagged proteins were purified with Glutathione 
Sepharose 4 Fast Flow beads (GE Healthcare) according to the manu-
facturer’s protocol. For protein samples used for acquiring the 15N 
HSQC NMR spectrum, the fusion tag was removed by 3C protease. 
Purified proteins were dialyzed in dialysis buffer [20 mM Hepes (pH 7.9), 
100 mM KCl, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 
15% glycerol, and 1 mM dithiothreitol (DTT)] at 4°C overnight.
Electrophoretic mobility shift assay
Partially purified recombinant proteins were incubated with 0.5 ng 
of radiolabeled DNA probe [except in Fig. 3 (D and E) and fig. S1 
(K, L, and O), where 0.25 ng of the probe was used] in 15 l of 1× 
DNA EMSA buffer [20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM 
MgCl2, 0.1 mM EDTA, bovine serum albumin (BSA; 100 ng/l), 5% 
glycerol, and 1 mM DTT] at room temperature for 30 min. EMSA 
loading dye (1.5 l) (50% glycerol, 0.1% bromophenol blue, and 
0.1% xylene cyanol) was added to each sample before it was electro-
phoresed in a 0.6% agarose gel in 0.5× tris-borate EDTA running 
buffer. Gels were dried and exposed to a phosphorimager.
In EMSA competition assays, unlabeled competitor was added 
to the reaction with the labeled probe in 1× DNA EMSA buffer first 
followed by adding recombinant proteins and incubation at room 
temperature for 30 min. Sequences of all probes used in this study 
are listed in table S3.
DNA probe preparation for EMSA
One hundred fifty nanograms of double-stranded linear DNA was 
radiolabeled using the Klenow fragment [New England Biolabs 
(NEB)] and 32P alpha 2′-deoxycytidine 5′-triphosphate (dCTP) in a 
50 l of reaction [50 mM tris (pH 6.8), 10 mM magnesium acetate, 
0.1 mM DTT, BSA (0.05 mg/ml), and 0.6 mM deoxynucleotide tri-
phosphates without dCTP] at room temperature for 60 min. The 
radiolabeled probe was purified by 3 ml of Sephadex G-50 column 
and precipitated overnight in 0.2 M sodium acetate (pH 5.5)/etha-
nol followed by washes with 70% ethanol and resuspension in 50 l 
of ddH2O.
DNA oligo (100 pmol) was radiolabeled using the T4 Polynucleotide 
Kinase (NEB) and 32P gamma adenosine triphosphate in 30 l of 
reaction [1× PNK (T4 polynucleotide kinase) buffer and 4.8% 
poly(ethylene glycol)] at 37°C for 60 min. The radiolabeled probe 
was purified by a QiaQuick nucleotide removal kit (Qiagen) according 
to the manufacturer’s protocol. Radiolabeled probes were size puri-
fied from 10% urea polyacrylamide gel and eluted in 400 l of 10 mM 
tris•Cl/1 mM EDTA (pH 8.0). Labeled oligo was precipitated overnight 
in 0.2 M sodium acetate (pH 5.5)/ethanol followed by washes with 
70% ethanol and was resuspended in 40 l of ddH2O.
Kd calculation
Densitometry data from fig. S1 (K and L) were obtained from 
ImageQuant (GE Healthcare). Titration curves were generated by plotting 
protein concentration (nanomolar) versus percentage shift of the radio-
labeled probe in Prism GraphPad. Kd was calculated using the fol-
lowing equation: Y = Bmax*X/(Kd + X) + NS*X, where Bmax is the 
maximum specific binding of radiolabeled probe, Kd is the equilib-
rium dissociation constant, and NS is the slope of nonspecific binding.
NMR titration assay
All 15N HSQC NMR experiments were performed at 298 K. Spectra 
were processed and analyzed using an AVANCE III 700 NMR spec-
trometer (Bruker). 15N HSQC experiments were acquired with 
samples in 20 mM sodium sulfate (pH 6.5), 150 mM NaCl, 1 mM 
EDTA, and 1 mM DTT. Concentration of 15N-labeled TbRAP1639–761 
and TbRAP1639–7615A is 0.1 mM. Two probes were used in NMR 
titration (purchased from Integrated DNA Technologies): random 
dsDNA (5′  TGTTGAGGAGGTGGTGAT 3′ /5 ′ATCAC-
CACCTCCTCAACA 3′) and telomeric dsDNA (5′ TTAGGGT-
TAGGGTTAGGG 3′/5′ CCCTAACCCTAACCCTAA 3′).
IF analyses
IF analyses were done the same way as described in (6).
VSG switching assay
VSG switching assay was performed, as described in (41). Detailed 
protocol can be found in the Supplementary Materials.
RNAseq and data analysis
The Cre expression was induced by doxycycline in TbRAP1F/+, 
TbRAP1F/−, TbRAP1F/5A, and TbRAP1F/2SD cells for 30 hours before 
total RNA was isolated and purified through RNeasy columns (Qiagen). 
All RNA samples were run on a Bioanalyzer 2100 (Agilent Tech-
nologies) using the Agilent RNA 6000 Nano Kit to verify the RNA 
quality before they were sent to Novogene for library preparation 
and RNA high-throughput sequencing followed by bioinformatic 
analysis. Details can be found in the Supplementary Materials.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/38/eabc4065/DC1
View/request a protocol for this paper from Bio-protocol.
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